Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of the prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance imaging with transurethral, therapeutic ultrasound and closed-loop thermal feedback control enables clinicians in the ablation of malignant tissues within the prostate. Profound Medical is headquartered in Mississauga, Ontario, Canada.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Profound Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Profound Medical Inc Company Overview
- Profound Medical Inc Company Snapshot
- Profound Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Profound Medical Inc - Pipeline Analysis Overview
- Profound Medical Inc - Key Facts
- Profound Medical Inc - Major Products and Services
- Profound Medical Inc Pipeline Products by Development Stage
- Profound Medical Inc Ongoing Clinical Trials by Trial Status
- Profound Medical Inc Pipeline Products Overview
- Sonalleve MR-HIFU System - Abdominal Cancers
- Sonalleve MR-HIFU System - Abdominal Cancers Product Overview
- Sonalleve MR-HIFU System - Breast Cancer
- Sonalleve MR-HIFU System - Breast Cancer Product Overview
- Sonalleve MR-HIFU System - Breast Cancer Clinical Trial
- Sonalleve MR-HIFU System - Hyperthermia
- Sonalleve MR-HIFU System - Hyperthermia Product Overview
- Sonalleve MR-HIFU System - Neuromodulation
- Sonalleve MR-HIFU System - Neuromodulation Product Overview
- Sonalleve MR-HIFU System - Pain Management
- Sonalleve MR-HIFU System - Pain Management Product Overview
- Sonalleve MR-HIFU System - Pain Management Clinical Trial
- Sonalleve MR-HIFU System - Pancreatic Cancer
- Sonalleve MR-HIFU System - Pancreatic Cancer Product Overview
- Tulsa-Pro System
- Tulsa-Pro System Product Overview
- Tulsa-Pro System Clinical Trial
- Profound Medical Inc - Key Employees
- Profound Medical Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Profound Medical Inc, Recent Developments
- Aug 04, 2021: Profound Medical Announces Second Quarter 2021 Financial Results
- Feb 09, 2021: Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 - Conference Call to Follow
- Feb 04, 2020: Profound Medical retires Bank debt ahead of schedule
- Jan 10, 2020: RadNet to Install the TULSA-PRO System for leading-edge customizable, incision-free prostate treatment
- Jan 10, 2020: Profound Medical and RadNet sign the first-ever U.S. multi-center commercial agreement for TULSA-PRO
- Dec 02, 2019: Novel MRI-guided ultrasound treatment destroys prostate cancer
- Nov 25, 2019: Profound Medical announces health canada approval of TULSA-PRO
- Oct 28, 2019: Profound Medical announces Nasdaq listing
- Aug 16, 2019: Profound Medical receives U.S. FDA 510(k) clearance for TULSA-PRO
- Aug 15, 2019: Accomplished financial executive, Steve Forte, joins Profound Medical’s board
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Profound Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Profound Medical Inc Pipeline Products by Equipment Type
- Profound Medical Inc Pipeline Products by Indication
- Profound Medical Inc Ongoing Clinical Trials by Trial Status
- Profound Medical Inc, Key Facts
- Profound Medical Inc, Major Products and Services
- Profound Medical Inc Number of Pipeline Products by Development Stage
- Profound Medical Inc Pipeline Products Summary by Development Stage
- Profound Medical Inc Ongoing Clinical Trials by Trial Status
- Profound Medical Inc Ongoing Clinical Trials Summary
- Sonalleve MR-HIFU System - Abdominal Cancers - Product Status
- Sonalleve MR-HIFU System - Abdominal Cancers - Product Description
- Sonalleve MR-HIFU System - Breast Cancer - Product Status
- Sonalleve MR-HIFU System - Breast Cancer - Product Description
- Sonalleve MR-HIFU System - Breast Cancer - Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer
- Sonalleve MR-HIFU System - Hyperthermia - Product Status
- Sonalleve MR-HIFU System - Hyperthermia - Product Description
- Sonalleve MR-HIFU System - Neuromodulation - Product Status
- Sonalleve MR-HIFU System - Neuromodulation - Product Description
- Sonalleve MR-HIFU System - Pain Management - Product Status
- Sonalleve MR-HIFU System - Pain Management - Product Description
- Sonalleve MR-HIFU System - Pain Management - Evaluation of Sonalleve MR-HIFU for Non-invasive Thermal Therapy of Facet-Joint Syndrome: Feasibility and Safety Clinical Study
- Sonalleve MR-HIFU System - Pancreatic Cancer - Product Status
- Sonalleve MR-HIFU System - Pancreatic Cancer - Product Description
- Tulsa-Pro System - Product Status
- Tulsa-Pro System - Product Description
- Tulsa-Pro System - A Randomized Control Trial of Focal Prostate Ablation Versus Radical Prostatectomy
- Tulsa-Pro System - Customized Ablation of the Prostate with the TULSA Procedure Against Radical Prostatectomy Treatment: A Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)
- Tulsa-Pro System - Customized TULSA-PRO Ablation Registry
- Tulsa-Pro System - Evaluation of the TULSA-PRO MRI-guided Transurethral Ultrasound Prostate Ablation Device in Patients with Localized Prostate Cancer: A Prospective, Single-arm, Pivotal Clinical Study
- Tulsa-Pro System - Feasibility and Safety of Transurethral HIFU in Various Prostate Diseases; Particularly Prostate Cancer
- Tulsa-Pro System - Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation
- Tulsa-Pro System - Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-guided Transurethral Ultrasound Ablation for Localized Prostate Cancer
- Tulsa-Pro System - Prospective Single Institutional Study Evaluating the Outcomes for Patients Undergoing Ablative Therapies in the Management of Clinically Localized Prostate Cancer in the Primary and Salvage Setting
- Profound Medical Inc, Key Employees
- Glossary
- Profound Medical Inc Pipeline Products by Equipment Type
- Profound Medical Inc Pipeline Products by Development Stage
- Profound Medical Inc Ongoing Clinical Trials by Trial Status
